Search Results

ValGenesis Inc. and Trinity Bridge Professional Services LLC have partnered to extend a suite of digital validation solutions from ValGenesis to help companies in the U.S. respond rapidly to increasingly dynamic environments.

Calyxt, Inc., a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture, announced that the registration statement on Form S-4, initially filed with the U.S. Securities and Exchange Commission by Calyxt on February 14, 2023, and amended on April 14, 2023, has been declared effective by the SEC.

CoagCo LLC, a Cleveland-based medical device company, announced that it has entered into an agreement with CHAMPS Group Purchasing, a group purchasing organization that leverages the purchasing power of more than 20,000 member locations across the U.S. to support supplier businesses and provide savings to its members.

Calyxt, Inc., a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture, announced that Calyxt has filed a registration statement on Form S-4 with the U.S. Securities and Exchange Commission on February 14, 2023.

Cellectis announced today that Cibus Global LLC and Calyxt, Inc. (NASDAQ: CLXT) (“Calyxt”), announced that Calyxt and Calypso Merger Subsidiary, LLC, a Delaware limited liability company and wholly-owned subsidiary of Calyxt, entered into an Agreement and Plan of Merger with Cibus and certain other parties named therein (the “Merger Agreement”), pursuant to which, subject to the terms and conditions thereof, Calyxt and Cibus will merge in an all-stock transaction.